• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 7.3: Heparin and Low Molecular Weight Heparins

    Neal Kleiman, MD — The Methodist Hospital, Baylor College of Medicine

    Duration:1 hour

    Faculty Disclosure

    • Grant and/or Research Support: Millennium Therapeutics; The Medicines Company
    • Consultant: Sanofi-Aventis

    Learning Objectives

    • Review the historical background of heparin, its activities, and dosage
    • Describe the clinical features of heparin-induced thrombocytopenia
    • Discuss low molecular weight heparins and pentasaccharide: comparative pharmacology and clinical trial results